Connect with us

Technology

MDA SPACE REPORTS FOURTH QUARTER AND FISCAL 2024 RESULTS

Published

on

Q4 2024 HighlightsBacklog of $4.4 billion at quarter-end, up 42% YoYRevenues of $347 million, up 69% YoYAdjusted EBITDA1 of $71 million, up 68% YoY; adjusted EBITDA margin1 of 20.5%Adjusted net income1 of $35 million, up 26% YoYFull year 2024 HighlightsRevenues of $1,080 million, up 34% YoYAdjusted EBITDA of $217 million, up 25% YoY; adjusted EBITDA margin of 20.1%Adjusted net income of $111 million, up 13% YoYOperating cash flow of $816 million; Free cash flow of $615 millionNet cash position of $167 million at year-endIntroduction of 2025 Financial OutlookRevenues expected to be $1.50 – $1.65 billion, representing ~ 45% YoY growthAdjusted EBITDA expected to be $290 – $320 million, representing ~ 40% YoY growth, with adjusted EBITDA margin of 19%-20%

BRAMPTON, ON, March 7, 2025 /PRNewswire/ – MDA Space Ltd. (TSX: MDA), a trusted space mission partner to the rapidly expanding global space industry, today announced financial results for the fourth quarter and year ended December 31, 2024.

“In 2024, the MDA Space team delivered another year of strong execution reflected in 34% and 25% increases in revenue and adjusted EBITDA, helping to further solidify our position as a trusted mission partner and leader in the expanding space industry,” said Mike Greenley, Chief Executive Officer of MDA Space.

“We continued to grow our backlog, securing the next phases of the Canadarm3 program valued at $1 billion, while advancing work on a number of important programs including the Telesat Lightspeed and Globalstar LEO constellations, Canadarm3 robotic program and MDA CHORUSTM, our next generation Earth observation constellation.”

“Post quarter-end, MDA Space was awarded a $1.1 billion contract from Globalstar to manufacture its next generation LEO constellation which will include 50+ MDA AURORATM digital satellites. This award marks our third LEO constellation contract in three years and our second constellation with Globalstar, further highlighting the continued momentum we are seeing in our Satellite Systems business driven by strong customer demand for our differentiated technology.”

“With a solid backlog of approximately $5 billion today, and a robust opportunity funnel, MDA Space is well positioned to deliver another successful year in 2025 as we continue to execute our strategy to capitalize on growing market demand and deliver shareholder value.”

____________________________________________

1 As defined in the “Non-IFRS Financial Measures” section

FULL YEAR 2024 HIGHLIGHTS

Order bookings for the full year totalled $2.4 billion and were largely driven by awards in our Robotics & Space Operations and Satellite Systems businesses. Backlog of $4.4 billion as of December 31, 2024 was up 41.6% compared to December 31, 2023.Full year revenues of $1,080.1 million were up 33.7% year-over-year, exceeding the Company’s full year revenue guidance of $1,045 – $1,065 million. The year-over-year increase was driven by execution on our backlog, with strong contributions from our Satellite Systems and Robotics & Space Operations businesses.Full year adjusted EBITDA of $217.1 million was up 24.6% year-over-year driven by higher volumes across our businesses. Adjusted EBITDA margin of 20.1% in 2024 is consistent with the Company’s full year margin guidance of 19%-20% and compares to 21.6% in 2023.Full year net income of $79.4 million was up 62.7% year-over-year due to higher operating income. Diluted earnings per share of $0.63 in 2024 were up 57.5% compared to 2023.Full year adjusted net income of $111.1 million was up 13.5% year-over-year driven by higher operating income. Adjusted diluted earnings per share of $0.88 in 2024 were up 8.6% year-over- year.Operating cash flow of $815.6 million in 2024 compared to $13.5 million in the prior year. The year-over-year increase in operating cash flow was driven by favourable working capital contributions primarily related to the Telesat Lightspeed program.Free cash flow of $614.8 million in 2024 compared to $(179.7) million in 2023. The year-over-year increase was driven by improving operating cash flow as a result of the aforementioned favourable working capital contributions.Net cash position of $166.7 million at year-end compared to net debt to adjusted EBITDA ratio of 2.4x as of December 31, 2023 as the Company utilized its strong operating cash flow in 2024 to make repayments to its revolving credit facility and deleverage the balance sheet while continuing to invest in its growth initiatives.

FOURTH QUARTER 2024 HIGHLIGHTS

Revenues of $346.6 million in Q4 2024 were up 69.1% year-over-year driven by strong contributions from Satellite Systems business.Adjusted EBITDA of $70.9 million in Q4 2024 was up 68.4% year-over-year driven by higher volume of work as we execute on our backlog. Adjusted EBITDA margin of 20.5% in Q4 2024 was in line with the 20.5% margin reported in Q4 2023 and consistent with the Company’s full year adjusted EBITDA margin guidance of 19%-20%.Net income of $25.1 million in Q4 2024 was up 85.9% year-over-year driven by higher operating income. Diluted earnings per share of $0.20 were up 81.8% year-over-year.Adjusted net income of $35.1 million in Q4 2024 was up 26.3% year-over-year largely due to higher operating income. Adjusted diluted earnings per share of $0.28 were up 21.7% year-over- year.Operating cash flow was $383.1 million in Q4 2024 compared to $(41.2) million in Q4 2023. The year-over-year increase in operating cash flow was driven by positive working capital contributions primarily related to the Telesat Lightspeed program and the Globalstar Authorization to Proceed (ATP) contract.

2025 FINANCIAL OUTLOOK

As a trusted mission partner and leading global space technology provider, we are leveraging our capabilities and expertise to execute on targeted growth strategies across our end markets and business areas. Our strategic initiatives, which span across our three businesses, include investing in next generation space technology and services, expanding our presence in high growth markets and geographies, scaling and expanding skills, talent and operations to meet current and future market demand and leveraging strategic M&A to complement organic growth. We continue to make good progress against our long-term strategic plan.

MDA Space is well positioned to capitalize on strong customer demand and robust market activity given our diverse and proven technology offerings. Our growth pipeline is significant and underpinned by existing and new programs and our book of business is healthy. We see activities ramping up in line with our expectations and are encouraged by the team’s solid execution.

For fiscal 2025, we expect full year revenues to be $1.50 – $1.65 billion, representing year-over-year growth of approximately 45% at the mid-point of guidance. We expect full year adjusted EBITDA to be $290 – $320 million, representing year-over-year growth of approximately 40% at the mid-point of guidance, and approximately 19% – 20% adjusted EBITDA margin. We expect capital expenditures to be $210 – $240 million in 2025, comprising of growth investments to support the previously outlined growth initiatives across our business areas. We expect full year free cash flow to be neutral to positive in 2025.

For Q1 2025, we expect revenues to be $315 – $335 million as we continue to execute on our backlog.

Note that the provided 2025 financial outlook does not incorporate any potential impact from the recently announced U.S. tariffs on articles imported from Canada or the retaliatory Canadian tariffs imposed on Canadian imports from the U.S. MDA Space continues to work collaboratively with our customers to identify solutions and explore mitigation strategies. The Company will continue to closely monitor developments and may elect to update its financial outlook if deemed necessary.

FINANCIAL OVERVIEW

KEY INDICATORS SUMMARY

Fourth Quarters Ended 

Years Ended

(in millions of Canadian dollars, except per

December 31,

December 31,

December 31,

December 31,

share data)

2024

2023

2024

2023

Revenues

$                 346.6

$                 205

$              1080.1

$              807.6

Gross profit

81.9

57.8

281.7

244.0

Gross margin

23.6 %

28.2 %

26.1 %

30.2 %

Adjusted EBITDA

70.9

42.1

217.1

174.2

Adjusted EBITDA margin

20.5 %

20.5 %

20.1 %

21.6 %

Adjusted Net Income

35.1

27.8

111.1

97.9

Adjusted Diluted EPS

$                   0.28

$                0.23

$                  0.88

$                0.81

 

As at

(in millions of Canadian dollars, except for ratios)   

December 31, 2024 

December 31, 2023

Backlog

$

4,385.5

$

3,097.0

Net debt(1) to Adjusted TTM(2) EBITDA ratio

(0.8)x

2.4x

(1) As defined in the ‘Non-IFRS Financial Measures’ section

(2) TTM: trailing twelve months

REVENUES BY BUSINESS AREA

Fourth Quarters Ended

Years Ended

December 31,

December 31,

December 31,

December 31,

(in millions of Canadian dollars)

2024

2023

2024

2023

Geointelligence

$                    47.4

$                 49.9

$               202.1

$               197.5

Robotics & Space Operations

64.7

64.9

279.8

248.4

Satellite Systems

234.5

90.2

598.2

361.7

Consolidated revenues

$                  346.6

$               205.0

$             1,080.1

$               807.6

Revenues

Consolidated revenues for the fourth quarter of 2024 were $346.6 million, representing an increase of $141.6 million (or 69.1%) from the fourth quarter of 2023. The year-over-year increase in revenues was primarily driven by strong contributions from our Satellite Systems business.

By business area, revenues in Geointelligence for the fourth quarter of 2024 were $47.4 million, which represents a decrease of $2.5 million (or 5.0%) from the same period in 2023 due to timing of programs. Revenues in Robotics & Space Operations for the fourth quarter of 2024 were $64.7 million, which represents a decrease of $0.2 million (or 0.3%) from the same period in 2023 driven by the gradual ramp of Phase C of the Canadarm3 Program which was awarded in Q2 2024. Revenues in Satellite Systems for the fourth quarter of 2024 were $234.5 million, which represents an increase of $144.3 million (or 160.0%) from the same period in 2023 driven by the ramp of the Telesat Lightspeed program and contributions from the Globalstar ATP which was awarded in Q4 2023.

Consolidated revenues for the year ended December 31, 2024 were $1,080.1 million, which were $272.5 million (or 33.7%) higher than 2023. The year-over-year increase in revenues was primarily driven by strong contributions from our Satellite Systems and Robotics & Space Operations businesses.

By business area, Revenues in Geointelligence for the year ended December 31, 2024 were $202.1 million, which represents a year-over-year increase of $4.6 million (or 2.3%) reflecting steady volume of work. Revenues in Robotics & Space Operations for the year ended December 31, 2024 were $279.8 million, which represents an increase of $31.4 million (or 12.6%) over 2023. The year-over- year revenue increase is primarily driven by the higher volume of work performed on the Canadarm3 program. Revenues in Satellite Systems for the year ended December 31, 2024 were $598.2 million, which represents an increase of $236.5 million (or 65.4%) over 2023 driven by the ramp up of the Telesat Lightspeed and contributions from the Globalstar ATP.

Gross Profit and Gross Margin

Gross profit reflects our revenues less cost of revenues. Q4 2024 gross profit of $81.9 million represents a $24.1 million (or 41.7%) increase over Q4 2023 driven by higher volumes of work performed in our Satellite Systems business. Gross margin in Q4 2024 was 23.6%, which is in line with our expectations, and compares to a gross margin of 28.2% in Q4 2023 driven by an evolving program mix and higher depreciation expense.

For the year ended December 31, 2024, gross profit of $281.7 million represents a $37.7 million (or 15.5%) increase over 2023 driven by higher volume of work performed year-over-year. Gross margin for the year ended December 31, 2024 was 26.1%, which is in line with our expectations driven by an evolving program mix and higher depreciation expense. Comparatively, gross margin in 2023 was 30.2%.

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA for the fourth quarter of 2024 was $70.9 million compared with $42.1 million for the fourth quarter of 2023, representing an increase of $28.8 million (or 68.4%) year-over-year driven by higher work volume as we continue to execute on our backlog. Adjusted EBITDA margin was 20.5% for the fourth quarter of 2024, in line with the 20.5% adjusted EBITDA margin reported for the fourth quarter of 2023 and consistent with the Company’s full year margin guidance of 19%-20%.

Adjusted EBITDA for the year ended December 31, 2024 was $217.1 million compared with $174.2 million for 2023, representing an increase of $42.9 million (or 24.6%) year-over-year. The improvement was driven by higher volume of work performed year-over-year and effective scaling of operating expenses. Adjusted EBITDA margin of 20.1% for the year ended December 31, 2024 is consistent with the Company’s full year margin guidance of 19%-20% and compares with 21.6% in 2023.

Adjusted Net Income

Adjusted net income for the fourth quarter of 2024 was $35.1 million compared with $27.8 million for the fourth quarter of 2023, representing an increase of $7.3 million (or 26.3%) year-over-year largely due to higher operating income in Q4 2024.

Adjusted net income for the year ended December 31, 2024 was $111.1 million compared with $97.9 million for the year ended December 31, 2023, representing an increase of $13.2 million (or 13.5%) year over year. The increase for the full year period is largely due to higher operating income.

Backlog

Backlog is comprised of our remaining performance obligations which represents the transaction price of firm orders less inception to date revenue recognized and excludes unexercised contract options and indefinite delivery or indefinite quantity contracts. Backlog as at December 31, 2024 was $4,385.5 million, an increase of $1,288.5 million compared with the backlog at December 31, 2023 driven by new order bookings partially offset by continued conversion of our backlog into revenue. The following table shows the build up of backlog for Q4 and the year ended December 31, 2024 as compared with the same periods in 2023. 

Fourth Quarters Ended  

Years Ended

(in millions of Canadian

December 31,

December 31,

December 31,

December 31,

dollars)

2024

2023

2024

2023

Opening Backlog

$             4,578.1 $

3,068.7 $

3,097.0 $

1,378.2

Less: Revenue recognized

(346.6)

(205.0)

(1,080.1)

(807.6)

Add: Order Bookings

154.0

233.3

2,368.6

2,526.4

Ending Backlog

$              4,385.5 $

3,097.0 $

4,385.5 $

3,097.0

CONFERENCE CALL AND WEBCAST

MDA will host a conference call and webcast to discuss these financial results on Friday, March 7, 2025 at 8:30 am ET. Interested parties can join the call by dialing 416-945-7677 (Toronto area) or 1-888-699-1199 (toll-free North America) or +44-800-279-7040 (United Kingdom) and entering the conference ID 07101. A live webcast of the conference call and an accompanying slide presentation will be available at https://mda-en.investorroom.com/events-presentations.

A replay of the conference will be archived on the MDA Space Investor Relations website following the call. Parties may also access a recording of the call which will be available until March 14, 2025, by dialing 1-888-660-6345 and entering the passcode 07101 #.

NON-IFRS FINANCIAL MEASURES

This press release refers to certain non-IFRS measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management’s perspective. Accordingly, the measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. We use non-IFRS measures, including EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Earnings per Share, Order Bookings, Net Debt and Free Cash Flow, to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS measures. We define EBITDA as net income (loss) before: i) depreciation and amortization expenses, ii) provision for (recovery of) income taxes, and iii) finance costs. Adjusted EBITDA is calculated by adding to and deducting from EBITDA, as applicable, certain expenses, costs, charges or benefits incurred in such period which in management’s view are either not indicative of underlying business performance or impact the ability to assess the operating performance of our business, including i) unrealized foreign exchange gain or loss ii) unrealized gain or loss on financial instruments and iii) share-based compensation expenses, and iv) other items that may arise from time to time. Adjusted EBITDA margin represents Adjusted EBITDA divided by revenue. Order Bookings is the dollar sum of contract values of firm customer contracts. Adjusted Net Income is calculated by adding to and deducting from net income, as applicable, certain expenses, costs, charges or benefits incurred in such period which in management’s view are either not indicative of underlying business performance or impact the ability to assess the operating performance of our business, including i) amortization of intangible assets related to business combinations, ii) unrealized foreign exchange gain or loss, iii) unrealized gain or loss on financial instruments, and iv) share-based compensation expenses, and iv) other items that may arise from time to time. Adjusted Earnings per Share represents Adjusted Net Income divided by the weighted average number of shares outstanding. Order Bookings is indicative of firm future revenues; however, it does not provide a guarantee of future net income and provides no information about the timing of future revenue. Net Debt is the total carrying amount of long-term debt including current portions, as presented in the 2024 Audited Financial Statements, less cash (or plus bank indebtedness) and excluding any lease liabilities. Net Debt is a liquidity metric used to determine how well the Company can pay all of its debts if they were due immediately. Free Cash Flow is a supplemental measure used to monitor the availability of discretionary cash generated, and available to the Company to repay debt, make strategic investments, and meet other payment obligations. We define Free Cash Flow as operating cash flows less net capital expenditures.

FORWARD-LOOKING STATEMENTS

This press release may contain forward looking information within the meaning of applicable securities legislation, which reflects the Company’s current expectations regarding future events. Forward looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward looking information. Such risks and uncertainties include, but are not limited to the factors discussed under “Risk Factors” in the Company’s Annual Information Form (AIF) dated March 7, 2025 and available on SEDAR+ at www.sedarplus.ca. MDA Space does not undertake any obligation to update such forward looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

ABOUT MDA SPACE

Building the space between proven and possible, MDA Space (TSX:MDA) is a trusted mission partner to the global space industry. A robotics, satellite systems and geointelligence pioneer with a 55-year+ story of world firsts and more than 450 missions, MDA Space is a global leader in communications satellites, Earth and space observation, and space exploration and infrastructure. The MDA Space team of more than 3,400 space experts in Canada, the US and the UK has the knowledge and know- how to turn an audacious customer vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that’s been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we’ll take you there. For more information, visit mda.space.

MDA Space Ltd.
Consolidated Statement of Comprehensive Income
For the years ended December 31, 2024 and 2023
(In millions of Canadian dollars except per share figures)

Year ended December 31

2024

2023

 

Revenue

 

$                             1,080.1

 

$                              807.6

Cost of revenue

Materials, labour and subcontractors

 

 

(754.6)

 

 

(532.0)

Depreciation and amortization of assets

(43.8)

(31.6)

Gross profit

281.7

244.0

Operating expenses

Selling, general and administration

 

 

(78.6)

 

 

(70.7)

Research and development, net

(36.9)

(39.3)

Amortization of intangible assets

(47.0)

(46.5)

Share-based compensation

(12.4)

(10.0)

Operating income

106.8

77.5

Other income (expenses)

Unrealized gain (loss) on financial instruments

 

 

1.2

 

 

(0.8)

Foreign exchange gain (loss)

17.5

(2.8)

Finance income

7.0

2.0

Finance costs

(28.0)

(8.6)

Other income

6.5

—

Income before taxes

111.0

67.3

Income tax recovery (expense)

(31.6)

(18.5)

Net income

79.4

48.8

Other comprehensive income

Loss on translation of foreign operations

 

 

(1.2)

 

 

(0.2)

Gain (loss) on cash flow hedges

1.0

(2.5)

Remeasurement gain on defined benefit plans

5.1

7.2

Total comprehensive income

$                                  84.3

$                                53.3

 

Earnings per share:

Basic

 

 

$                                  0.66

 

 

$                                0.41

Diluted

0.63

0.40

Weighted-average common shares outstanding:

Basic

120,088,519

119,253,279

Diluted

126,049,042

121,176,848

MDA Space Ltd.
Consolidated Statement of Financial Position
December 31, 2024 and 2023
(In millions of Canadian dollars)

As at December 31

2024

2023

Assets

Current assets:

Cash

$                 166.7

$                        22.5

Trade and other receivables

75.9

169.5

Unbilled receivables

250.1

183.1

Inventories

8.1

9.9

Income taxes receivable

54.0

47.3

Other current assets

71.7

24.3

 

Non-current assets:

626.5

456.6

Property, plant and equipment

496.6

369.1

Right-of-use assets

115.4

71.8

Intangible assets

580.0

582.5

Goodwill

441.0

439.8

Deferred income tax assets

9.9

14.9

Other non-current assets

328.1

227.0

1,971.0

1,705.1

Total assets

2,597.5

2,161.7

Liabilities and shareholders’ equity

Current liabilities:

Accounts payable and accrued liabilities

 

 

 

248.7

 

 

 

219.1

Income taxes payable

1.9

4.4

Contract liabilities

761.3

76.9

Current portion of net employee benefit payable

60.2

57.4

Current portion of lease liabilities

16.2

10.9

Other current liabilities

2.7

4.5

 

Non-current liabilities:

1,091.0

373.2

Net employee defined benefit payable

23.7

22.8

Lease liabilities

120.6

75.2

Long-term debt

—

438.9

Deferred income tax liabilities

185.4

180.8

Other non-current liabilities

0.8

6.1

Total liabilities

1,421.5

1,097.0

Shareholders’ equity

Common shares

 

975.8

 

956.1

Contributed surplus

38.0

31.3

Accumulated other comprehensive income

23.5

18.6

Retained earnings

138.7

58.7

Total equity

1,176.0

1,064.7

Total liabilities and equity

$              2,597.5

$                   2,161.7

MDA Space Ltd.

Consolidated Statement of Cash Flows
For the years ended December 31, 2024 and 2023
(In millions of Canadian dollars)

Year ended December 31

2024

2023

Cash flows from operating activities

Net income

 

$

 

79.4

 

$

 

48.8

Items not affecting cash:

Income tax expense

 

31.6

 

18.5

Depreciation of property, plant, and equipment

19.8

13.1

Depreciation of right-of-use assets

11.9

9.6

Amortization of intangible assets

59.3

55.4

Gain on disposal of assets

(5.8)

—

Write-down of assets

3.3

4.8

Equity-settled share-based compensation

10.4

10.0

Investment tax credits accrued

(42.6)

(33.3)

Finance costs, net

21.0

6.6

Unrealized (gain) loss on financial instruments

(1.2)

0.8

Changes in operating assets and liabilities

639.4

(95.6)

826.5

38.7

Interest paid

(25.4)

(18.5)

Income tax received (paid)

14.5

(6.7)

Net cash generated in operating activities

815.6

13.5

 

Cash flows from investing activities

Purchases of property and equipment

 

 

(138.2)

 

 

(148.0)

Purchases/development of intangible assets

(62.6)

(45.2)

Proceeds from disposal of assets

7.4

—

Acquisition of subsidiary, net of cash

(27.3)

(24.4)

Investment in equity securities

(9.2)

—

Net cash used in investing activities

(229.9)

(217.6)

 

Cash flows from financing activities

Borrowings from senior credit facility

 

 

110.0

 

 

—

Repayments to senior credit facility

(550.0)

195.0

Transaction costs incurred on debt refinancing

—

—

Payment of lease liability (principal portion)

(7.9)

(8.4)

Proceeds from stock options exercised

11.8

0.8

Net cash provided by (used in) financing activities

(436.1)

187.4

 

Net increase (decrease) in cash

 

149.6

 

(16.7)

Net foreign exchange difference on cash

(5.4)

(0.1)

Cash, beginning of period

22.5

39.3

Cash, end of period

$

166.7

$

22.5

RECONCILIATION OF NON-IFRS MEASURES

The following table provides a reconciliation of net income to EBITDA, adjusted EBITDA, and adjusted net income: 

Fourth Quarters Ended  

Years Ended

December 31,

December 31,

December 31,

December 31,

(in millions of Canadian dollars)

2024

2023

2024

2023

Net income

$                      25.1

$                      13.5 $

79.4

$                      48.8

Depreciation and amortization of assets

12.7

9.2

43.8

31.6

Amortization of intangible assets related to business combination

11.5

11.7

47.0

46.5

Income tax expense

11.3

(0.1)

31.6

18.5

Finance income

(3.3)

(0.2)

(7.0)

(2.0)

Finance costs

9.6

0.1

28.0

8.6

EBITDA

$                      66.9

$                      34.2 $

222.8

$                    152.0

Unrealized foreign exchange loss (gain)

(3.6)

2.2

(14.0)

4.7

Unrealized (gain) loss on financial instruments

—

0.7

(1.2)

0.8

Impairment of assets

3.3

—

3.3

4.8

Gain on disposal of assets

—

—

(5.8)

—

Acquisition, integration and reorganization costs

1.6

1.9

1.6

1.9

Equity-settled share-based compensation

2.7

3.1

10.4

10.0

Adjusted EBITDA

$                      70.9

$                      42.1 $

217.1

$                    174.2

 

Fourth Quarters Ended

Years Ended

December 31,

December 31,

December 31,

December 31,

(in millions of Canadian dollars)

2024

2023

2024

2023

Net income

$                     25.1  $

13.5

$                      79.4

$                   48.8

Amortization of intangible assets related

11.5

11.7

47.0

46.5

to business combination

Impairment of assets

3.3

—

3.3

4.8

Acquisition, integration and

1.6

1.9

1.6

1.9

reorganization costs

Gain on disposal of assets

—

—

(5.8)

—

Unrealized (gain) loss on financial

—

0.7

(1.2)

0.8

instruments

Net foreign exchange (gain) loss

(8.8)

2.0

(17.5)

2.8

Embedded derivative effects

(1.4)

—

0.8

—

Hedge derecognition cost

4.7

—

4.7

—

Equity-settled share-based

2.7

3.1

10.4

10.0

compensation

Income taxes related to the above items (1)

(3.6)

(5.1)

(11.6)

(17.7)

Adjusted Net income

$                     35.1  $

27.8

$                   111.1

$                   97.9

(1) Standard income tax rate of 26.5% applied

View original content to download multimedia:https://www.prnewswire.com/news-releases/mda-space-reports-fourth-quarter-and-fiscal-2024-results-302395289.html

SOURCE MDA Space

Continue Reading

Technology

Best AI Tools for Marketing Content (2026): CapCut Recognized for Faster AI-Powered Video and Image Creation by Better Business Advice

Published

on

By

NEW YORK, Oct. 24, 2026 /PRNewswire/ — Better Business Advice has recognized CapCut in its 2026 coverage of the best AI tools for marketing content, highlighting its collection of AI-powered features for creating and editing videos, images, audio, and other campaign assets. The recognition reflects growing interest in tools that help transform creative concepts into usable marketing materials while reducing the manual work involved in production.

Best AI Marketing Tools

Seedance 2.0 – an AI video generation model that creates videos from text prompts or imagesSeedream – an AI image generation model that creates high-quality visuals from text prompts

AI-powered content creation is changing how businesses develop digital marketing campaigns. From promotional videos and product imagery to social media graphics and branded audio, organizations face growing demand for creative assets across multiple digital channels. Tools that simplify production and support faster experimentation are becoming an increasingly important part of modern marketing workflows.

CapCut offers a range of AI-assisted capabilities covering several stages of content creation. These include text-based video generation, AI image generation, background removal, image expansion, music generation, and photo animation. Together, the tools provide options for producing marketing assets for social media, digital advertising, product promotions, and other online campaigns.

AI Video Generation Supports Promotional Campaigns

Video is an important format for communicating product information, presenting services, and building audience engagement. However, producing video content regularly can require significant planning, editing, and creative resources.

CapCut’s Seedance 2.0 AI video generator supports prompt-based video creation. Users can describe a creative concept and generate video content that serves as a starting point for further development.

The capability can support promotional videos, product showcases, educational content, and social media campaigns. It also gives creators a way to explore different visual approaches during the planning stage before refining the selected direction.

For businesses producing content across multiple channels, AI-assisted video generation can help reduce the effort required to develop initial concepts. Generated material can then be reviewed and edited to align with campaign objectives, brand guidelines, and platform requirements.

Image Generation Helps Develop Marketing Concepts

Visual assets influence how products, services, and campaigns are presented to audiences. Developing suitable imagery often involves several rounds of brainstorming and creative testing before a final direction is selected.

CapCut’s Seedream AI image generator enables users to create images from text prompts. The tool can support concept drafts, campaign planning, and experimentation with different visual styles.

For example, a seasonal marketing campaign may require several approaches to backgrounds, compositions, and visual themes. AI-generated drafts can help illustrate those options before resources are committed to final production.

CapCut’s GPT Image 2 provides another option for generating images from natural language instructions. The feature can support the development of promotional graphics, campaign imagery, and other visual assets.

These tools help shorten the early stages of creative development by making it easier to turn written ideas into visual references. Human review remains important to ensure the resulting assets accurately represent the product and meet the campaign’s requirements.

Image Editing Simplifies Asset Preparation

AI image generation is only one part of preparing content for publication. Existing photographs and graphics often need adjustments before they can be used across marketing channels.

CapCut’s AI background removal tool helps separate subjects from their original backgrounds. This can be useful when preparing product images, promotional graphics, and other assets that require a different visual setting.

The AI Image Extender addresses the challenge of adapting images to different layouts. By generating content beyond an image’s original boundaries, the tool can help users adjust compositions for different formats without relying entirely on cropping or stretching.

These capabilities can support the preparation of visuals for social media posts, website banners, digital advertisements, and product promotions. They also provide options for repurposing existing creative assets instead of producing entirely new images for every placement.

AI Audio and Photo Animation Expand Creative Options

Marketing content often combines visuals, movement, and sound to communicate a message. Producing these elements separately can add complexity to the creative process.

CapCut’s SeedMusic AI audio generator supports AI-assisted music creation based on creative prompts. Generated music can be used as a starting point for videos, promotional campaigns, and other multimedia projects, subject to appropriate review and usage requirements.

The platform’s Photo-to-3D tool offers another way to adapt still images into more dynamic visual content. This capability can help transform existing photography into animated presentations for product showcases, social media, and digital promotions.

By supporting audio creation and image animation alongside video and image tools, CapCut provides additional options for developing varied marketing materials.

A Connected Workflow for Marketing Content

CapCut’s collection of AI-powered features supports several stages of campaign production within one creative environment. A project could begin with concept images generated through Seedream, followed by visual development with GPT Image 2. Background removal and image expansion can then help prepare assets for different placements.

Selected visuals can be incorporated into video projects using Seedance 2.0, while SeedMusic offers an option for developing accompanying audio. Photo-to-3D can provide another format for repurposing existing images.

Not every campaign requires all these capabilities. Their practical value depends on the content format, production requirements, and intended audience. Reviewing generated assets for accuracy, visual consistency, and suitability remains essential before publication.

Better Business Advice’s recognition of CapCut reflects the growing role of AI-assisted production in digital marketing. As businesses continue to develop content for multiple channels, tools that support video creation, image generation, editing, and multimedia production can help simplify creative workflows while leaving room for human direction and quality control.

The full article can be read at the Better Business Advice website.

About CapCut

CapCut is an AI-powered photo and video editing platform designed to make high-quality video creation accessible across devices. The platform supports creators, businesses, and everyday users with tools for video editing, AI video generation, captions, templates, audio, and visual editing. CapCut is available across mobile, web, desktop, and iPad experiences, helping users create, edit, and prepare video content for social media, marketing, education, and personal projects.

About Better Business Advice: Better Business Advice covers the news and strategies driving modern business success. The information provided by Better Business Advice does not, and is not intended to, constitute legal advice; instead, all information, content, and materials are for general informational purposes only. As an affiliate, Better Business Advice may earn commissions from services mentioned in the links provided.

View original content:https://www.prnewswire.com/news-releases/best-ai-tools-for-marketing-content-2026-capcut-recognized-for-faster-ai-powered-video-and-image-creation-by-better-business-advice-302918030.html

SOURCE BetterBusinessAdvice.com

Continue Reading

Technology

Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026

Published

on

By

GUANGZHOU, China, Oct. 24, 2026 /PRNewswire/ — Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation of clinical data for BAT8008, a TROP2-targeted antibody-drug conjugate (ADC), in combination with BAT1308, an anti-PD-1 monoclonal antibody, at the 2026 European Society for Medical Oncology (ESMO) Congress. Professor Shaodong Hong of Sun Yat-sen University Cancer Center delivered a rapid oral presentation highlighting results from the combination regimen in patients with non-small cell lung cancer (NSCLC). Further details are available on Bio-Thera’s official website.

In the first-line, mutation-negative NSCLC population (N=104), treatment with BAT8008 in combination with BAT1308 achieved an objective response rate (ORR) of 61.2% and a median progression-free survival (PFS) of 12.42 months. In the non-squamous NSCLC subgroup, the ORR was 65.2%, while median PFS had not yet been reached at the time of analysis. The combination demonstrated a manageable safety profile consistent with the known safety characteristics of the individual agents, with no new safety signals identified.

“We are very encouraged by these Phase 2 results evaluating BAT8008 in combination with BAT1308 as a first-line treatment for advanced non-small cell lung cancer”, said Shengfeng Li, CEO of Bio-Thera Solutions.  “The findings support the potential of this combination approach in First Line NSCLC and reinforce our commitment to advancing innovative oncology therapies for patients with significant unmet medical needs.”

Lung cancer remains a major global health challenge, and NSCLC accounts for the majority of lung cancer cases. Patients with advanced NSCLC who lack actionable genomic alterations continue to face significant treatment challenges, despite advances in immunotherapy and chemoimmunotherapy. New treatment strategies that can improve clinical outcomes while maintaining a manageable safety profile remain an important area of oncology research.

TROP2-targeted ADCs combine tumor-directed delivery of cytotoxic payloads with the potential to modulate the tumor microenvironment. When combined with PD-1 blockade, this approach may offer complementary mechanisms of action, providing a rationale for clinical investigation in NSCLC. The clinical findings presented at ESMO 2026 support further evaluation of BAT8008 in combination with BAT1308 as a potential treatment option for patients with NSCLC.

About Bio-Thera Solutions:

Bio-Thera Solutions, Ltd., a leading innovative, global biopharmaceutical company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs, as well as biosimilars for existing, branded biologics to treat a range of cancer and autoimmune diseases. As a leader in next generation antibody discovery and engineering, the company has advanced multiple candidates into late-stage development, including six approved products: QLETLI® (adalimumab) and BETAGRIN® (bevifibatide citrate) Injection in China, STARJEMZA® (ustekinumab) in the US and USYMRO® (ustekinumab) in the EU, TOFIDENCE®/BAT1806 (tocilizumab) and AVZIVI® (bevacizumab-tnjn) in the US and in the EU, a/k/a POBEVCY® in China, and GOTENFIA® (golimumab) in the EU and IMMGOLIS™ (golimumab-sldi) in the US. In addition, the company has more than 20 promising candidates in clinical trials, focusing on immuno-oncology in the post-PD-1 era and targeted therapies such as antibody-drug conjugates (ADCs). For more information, please visit www.bio-thera.com/en/ or follow us on X (@bio_thera_sol) and WeChat (Bio-Thera).

Bio-Thera Cautionary Note Regarding Forward-Looking Statements

This news release contains certain forward-looking statements relating to BAT8008, BAT1308 or the product pipelines in general of Bio-Thera Solutions. Readers are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. The forward-looking statements include, among others, those containing “could,” “may,” “should,” “will,” “would,” “anticipate,” “believe,” “plan,” “promising,” “potentially,” or similar expressions. They reflect the company’s current views with respect to future events that are based on what the company believes are reasonable assumptions in view of information currently available to Bio-Thera Solutions, and are not a guarantee of future performance or developments. Actual results and events may differ materially from information contained in the forward-looking statements as a result of a number of factors, including, but not limited to, risks and uncertainties inherent in pharmaceutical research and development, such as the uncertainties of pre-clinical and clinical studies. Other risks and uncertainties include challenges in obtaining regulatory approvals, manufacturing, marketing, competition, intellectual property, product efficacy or safety, changes in global healthcare situation, changes in the company’s financial conditions, and changes to applicable laws and regulations, etc. Forward-looking statements contained herein are made only as of the date of their initial publication. Unless required by laws or regulations, Bio-Thera Solutions undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, changes in the company’s views or otherwise.

Bio-Thera Contact:
Bert E. Thomas IV
Phone: +1.410.627.1734
Email: bethomas@bio-thera.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-thera-announces-promising-clinical-data-for-bat8008-in-combination-with-bat1308-in-first-line-non-small-cell-lung-cancer-at-esmo-2026-302918492.html

SOURCE Bio-Thera Solutions, Ltd

Continue Reading

Technology

ASTRI Showcases Pioneering Technologies at InnoCarnival 2026

Published

on

By

Driving Technology Adoption, Shaping a Vision for the Future

HONG KONG, Oct. 24, 2026 /PRNewswire/ — The Hong Kong Applied Science and Technology Research Institute (ASTRI) is proud to present a range of cutting-edge technologies and practical solutions at this year’s InnoCarnival, spanning communications technology, smart cities, IoT sensing, and renewable energy and energy storage. ASTRI’s innovations address urban development needs and everyday applications, driving diversity in the innovation and technology (I&T) sector.

Organised by the Innovation and Technology Commission of the Hong Kong SAR Government, the InnoCarnival 2026 runs from today through 1 November at Hong Kong Science Park (HKSP) with the theme of “Lead with I&T, Dream to Fly High “, offering the public an opportunity to experience the transformative power and I&T vibrancy.

Ir Dr Ted Suen, Chief Executive Officer of ASTRI, stated: “Innovation is not just about breakthroughs in the lab – it’s about putting technology into practice, empowering industries, and benefiting society as a whole. At ASTRI, we align closely with the government’s priorities in advancing AI development and accelerating new industrialisation. Through our participation in the InnoCarnival, we showcase various state-of-the-art technologies, some of which have been co-developed with industry partners and are already in commercial rollout. These innovations demonstrate the tangible benefits of technology in daily life and inspire the public to explore their curiosity about science and innovation.”

He highlighted the InnoCarnival as a key platform to bridge the I&T community with the public. “This annual landmark event motivates young people to explore their potential and encourages them to pursue careers in Hong Kong’s growing I&T sector,” he added.

ASTRI’s booth (A08), located at the HKSP’s Atrium Link, features interactive games powered by its groundbreaking technologies “5G-SAT Link” and “Omniguard-All-Weather Multispectral Surveillance System” technologies. Visitors can also explore other advanced solutions on display, including the dual-purpose “SafeStop Dual-purpose Impact Dissipation Bollard”, the “Hybrid-Powered Asset Tracker”, and the award-winning “NIR Secure Anti-Counterfeit Solutions”, which received gold award at the prestigious Edison Awards.

1. 5G-SAT Link
ASTRI’s “5G-SAT Link” technology delivers seamless, comprehensive communications coverage—even in remote areas, emergency scenarios where infrastructure is compromised, or at sea and in the air.

2. Omniguard: All-Weather Multispectral Surveillance System
The “Omniguard” is equipped with exceptional fog penetration capabilities, superior contrast, and crystal-clear signal quality. Leveraging its advanced shortwave and longwave infrared sensors, the system can even detect non-metallic vessels that are difficult for radar systems to identify in harsh coastal environments.

3. SafeStop Dual-purpose Impact Dissipation Bollard
Developed by ASTRI, the “SafeStop Bollard” features a unique material design inspired by the retractable claw structure of cats. Its 3D tension-expansion composition allows it to effectively dissipate kinetic energy from moving vehicles, providing dual protection by blocking vehicles while minimising potential harm to occupants. Certified to meet international crash-test standards, the bollard’s shallow foundation design makes it ideal for fast and efficient installation in high-traffic urban locations.

4. Hybrid-Powered Asset Tracker
The “Hybrid-Powered Asset Tracker” enables efficient, real-time management of airport equipment such as baggage carts over extended periods. Supported by the Airport Authority Hong Kong, the tracker is compatible with airport wireless networks and utilises automatic Bluetooth-GPS switching for seamless indoor and outdoor location updates. With a long-lasting battery combined with an efficient, low-light solar panel, the tracker extends its lifespan from under two years to five years.

5. NIR Secure Anti-Counterfeit Solutions
The “NIR Secure Anti-Counterfeit Solutions” offer an innovative authentication system by embedding covert near-infrared (NIR) absorbing materials into product packaging. Users can verify product authenticity instantly using a smartphone, paired with an NIR reader and mobile app. Highly scalable and robust, this solution combats counterfeit goods while preserving the original product design and production workflow. Co-developed with Zhuhai Print-Rite New Materials Corporation Ltd., this technology sets a new benchmark in secure authentication.

Photos Download: https://bit.ly/4iguifh

About ASTRI

Founded in 2000 by the HKSAR Government, Hong Kong Applied Science and Technology Research Institute (ASTRI) is the city’s largest government-funded R&D centre. Committed to transforming high-impact research into practical innovations, ASTRI drives market-driven, interdisciplinary advancements across sectors, including Smart City, FinTech, Digital Health and Life Sciences, New Industrialisation and Intelligent Manufacturing, Application-Specific Integrated Circuits (ASIC) and Advanced Electronics, New Energy and Energy Storage, and Green and ESG Technologies. Following its merger with the Nano and Advanced Materials Institute, ASTRI has further strengthened its capabilities, with over 1,500 patents and 2,200 successful cases of technology transfer. Recognised with numerous international awards, ASTRI continues to nurture top I&T talent and foster collaborations among the I&T ecosystem, contributing to Hong Kong’s high-value economic development. For more information, please visit: https://www.astri.org 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/astri-showcases-pioneering-technologies-at-innocarnival-2026-302918617.html

SOURCE Hong Kong Applied Science and Technology Research Institute (ASTRI)

Continue Reading

Trending